Pfizer expands COVID booster to 16, 17 year-olds; can the system handle them?

The U.S. Food and Drug Administration has made another large group of people, 16 and 17-year olds, eligible for the Pfizer vaccine booster shot to battle the COVID omicron variant. The question is: will there be enough vaccine to serve them in addition to the vast population already eligible?